September 30, 2020 – Medtronic plc (Dublin, Ireland) announced the planned acquisition of Avenu Medical (San Juan Capistrano, CA), a privately held medical device company focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis.
Avenu Medical’s Ellipsys Vascular Access System is a single-catheter, ultrasound-guided device that inserts a catheter percutaneously (through the skin) into the arm to create a durable AV fistula. The procedure can be performed in the hospital outpatient department, ambulatory surgery center (ASC), or physician’s office.
The Ellipsys Vascular Access System has been approved by the FDA and is CE Marked for distribution in the European Union. It is indicated in both geographies for the creation of a proximal radial artery to perforating vein anastomosis for percutaneous creation of an AV fistula.
The acquisition of Avenu Medical is the sixth in a series of tuck in acquisitions that Medtronic has made in 2020.
The acquisition is expected to close in October, subject to the satisfaction of certain customary closing conditions. Terms of the transaction were not disclosed.